Pierre Blier

Serotonin receptor 1A knockout: An animal model of anxiety-related disorder

Sylvie Ramboz, Ronald S. Oosting, Djamel Aït Amara et al. · Proceedings of the National Academy of Sciences · 1998 · 810 citations

Life Sciences, Neuroscience, Psychology +17

Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression

Ella Daly, Madhukar H. Trivedi, Adam Janik et al. · JAMA Psychiatry · 2019 · 759 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +17

Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)

Maggie Fedgchin, Madhukar H. Trivedi, Ella Daly et al. · The International Journal of Neuropsychopharmacology · 2019 · 590 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Modification of 5‐HT neuron properties by sustained administration of the 5‐HT_1A agonist gepirone: Electrophysiological studies in the rat brain

Pierre Blier, Claude de Montigny · Synapse · 1987 · 428 citations

Medicine, Neuroscience, Pharmacology +17

Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial

Jennifer L. Phillips, Sandhaya Norris, Jeanne Talbot et al. · American Journal of Psychiatry · 2019 · 411 citations

Medicine, Pharmacology, Pharmacotherapy +16